Search





Search





Markets
/
Stocks
/
nasdaq-erna
/

Eterna Therapeutics Inc

ERNA

Add to Watchlist

6.200USD

+0.310+5.26%

Close 06/18, 16:00（ET）Quotes delayed by 15 min

289.17KMarket Cap

LossP/E TTM

Eterna Therapeutics Inc

6.200

+0.310+5.26%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Eterna Therapeutics Inc's Company Valuation

Currency: USD Updated: 2026-06-18

Previous score

9.20

Change

0

The current valuation score of Eterna Therapeutics Inc is 9.20, ranking 48 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.04, which is -174.44% below the recent high of 0.03 and -9616.39% above the recent low of -3.50.

P/E

Relevant data have not been disclosed by the company yet.

P/B

Relevant data have not been disclosed by the company yet.

P/S

Relevant data have not been disclosed by the company yet.

P/CF

Relevant data have not been disclosed by the company yet.

KeyAI

